Lentiviral gene therapy for mucopolysaccharidosis type IVA

被引：0
|
作者：
Celik, Betul [1 ]
Rintz, Estera [2 ]
Nidhi, Fnu [3 ]
Khan, Shaukat [4 ]
Tomatsu, Shunji [5 ]
机构：
[1] Univ Delaware, Biol Sci, Newark, DE USA
[2] Univ Gdansk, Gdansk, Poland
[3] Univ Delaware, Newark, DE USA
[4] Nemours Alfred I Pont Hosp Children, Wilmington, DE USA
[5] Nemours Alfred I Pont Hosp Children, Biomed Res & Orthoped, Wilmington, DE USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
64
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [21] Pre-clinical workup of lentiviral mediated stem cell gene therapy for mucopolysaccharidosis type IIIA
    Ellison, S. M.
    Sergijenko, A.
    Langford-Smith, A.
    Langford-Smith, K.
    Wynn, R.
    Wilkinson, F.
    Bigger, B.
    HUMAN GENE THERAPY, 2015, 26 (10) : A16 - A16
  • [22] Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
    Bertolin, Joan
    Sanchez, Victor
    Ribera, Albert
    Jaen, Maria Luisa
    Garcia, Miquel
    Pujol, Anna
    Sanchez, Xavier
    Munoz, Sergio
    Marco, Sara
    Perez, Jennifer
    Elias, Gemma
    Leon, Xavier
    Roca, Carles
    Jimenez, Veronica
    Otaegui, Pedro
    Mulero, Francisca
    Navarro, Marc
    Ruberte, Jesus
    Bosch, Fatima
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [23] Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
    Joan Bertolin
    Víctor Sánchez
    Albert Ribera
    Maria Luisa Jaén
    Miquel Garcia
    Anna Pujol
    Xavier Sánchez
    Sergio Muñoz
    Sara Marcó
    Jennifer Pérez
    Gemma Elias
    Xavier León
    Carles Roca
    Veronica Jimenez
    Pedro Otaegui
    Francisca Mulero
    Marc Navarro
    Jesús Ruberte
    Fatima Bosch
    Nature Communications, 12
  • [24] Delayed diagnosis of mild mucopolysaccharidosis type IVA
    Yi, Mengni
    Shen, Pinquan
    Zhang, Huiwen
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [25] Cochlear implantation in a patient with mucopolysaccharidosis type IVA
    Tomatsu, Shunji
    Nagao, Kyoko
    Walter, Cassidy
    Parkes, William J.
    Teixido, Michael
    Theroux, Mary C.
    Szymkowsk, Stacy
    Morlet, Thierry
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S153 - S153
  • [26] Pre-clinical development of an ex-vivo lentiviral-based Hematopoietic Stem/Progenitor Cells (HSPC)-gene therapy (GT) approach for Mucopolysaccharidosis type IVA (MPSIVA)
    Crippa, S.
    Quaranta, P.
    Berti, M.
    Santi, L.
    De Ponti, G.
    Jofra-Hernandez, R.
    Basso-Ricci, L.
    Rilievo, A. A.
    Alberti, G.
    Forni, C.
    Visigalli, I.
    Albertini, P.
    Paoli, A.
    Morrone, A.
    Parini, R.
    Gentner, B.
    Scala, S.
    Aiuti, A.
    Bernardo, M. E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A170 - A171
  • [27] Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
    Ou, Li
    Przybilla, Michael J.
    Koniar, Brenda L.
    Whitley, Chester B.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2016, 8 : 87 - 93
  • [28] Gene therapy for murine mucopolysaccharidosis type VII
    Sands, MS
    Wolfe, JH
    Birkenmeier, EH
    Barker, JE
    Vogler, C
    Sly, WS
    Okuyama, T
    Freeman, B
    Nicholes, A
    Muzyczka, N
    Chang, PL
    Axelrod, HR
    NEUROMUSCULAR DISORDERS, 1997, 7 (05) : 352 - 360
  • [29] The potential of gene therapy for mucopolysaccharidosis type I
    Pimentel Vera, Luisa Natalia
    Baldo, Guilherme
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (01): : 33 - 41
  • [30] Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy
    Donida, Bruna
    Marchetti, Desiree P.
    Biancini, Giovana B.
    Deon, Marion
    Manini, Paula R.
    da Rosa, Helen T.
    Moura, Dinara J.
    Saffi, Jenifer
    Bender, Fernanda
    Burin, Maira G.
    Coitinho, Adriana S.
    Giugliani, Roberto
    Vargas, Carmen Regla
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (05): : 1012 - 1019
12345